Hi, what are you looking for?
BioLineRx's current portfolio consists of a variety of clinical and pre-clinical projects.
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Please help us...
– Initial results for BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis) – CEO Kinneret Savitsky – BioLineRx (NASDAQ:...
– BioLineRx has signed an agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. (CTTQ) for the development and commercialization of BL-8030, an oral treatment...
In the 15th Nov 2015 edition of Israel’s good news, the highlights include: · A new Israeli treatment brings hope to relapsed leukemia...
In the 14th Jun 2015 edition of Israel’s good news, the highlights include: Two Israeli successes in the fight against diabetes. The UN...
· An Israeli electrical device extends the life of brain tumor patients. · Israeli experts are helping Kenya save wildlife from poachers. · Israeli bio sensors are...
– Teva is resuming investments in Israeli startups. Sources inform ”Globes” that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Philips Healthcare jointly bid in the Office...
– In the 9th March edition of Israel’s good news: ECONOMY & BUSINESS Israel’s cyber industry. Israel National Cyber Bureau (INCB) has estimated exports...
UK based Edison Investment Research, which describes itself as an “investment intelligence company”, has just announced it has extended the company’s presence to Israel...